Liminatus Pharma, Inc. (LIMNW) Warrants
Each LIMNW warrant gives the holder the right to buy 1/50 share of Liminatus Pharma, Inc. at $575.00 per share, until April 30, 2030. The stock last closed at $2.81, below the strike, so the warrant is out of the money. Liminatus Pharma, Inc. has a market value of about $3.77M. There are 5.09M listed warrants; exercising all of them would add 7.6% to the 1.34M shares outstanding. The company can call the warrants if the stock trades at or above $900.00.
Liminatus Pharma, Inc. reports its business to the SEC as “Biological Products, (No Diagnostic Substances)”, with its head office in Cerritos, CA; it is incorporated in Delaware. The LIMNW warrants were first issued by a SPAC and became Liminatus Pharma, Inc. warrants when the merger closed on April 30, 2025. Its latest SEC filing was on November 18, 2026: current report (other events), form 8-K. The warrant closed at $0.0422 on November 19, 2026, down 60% from $0.1051 on November 21, 2025. LIMN trades at 0.49% of the strike; it would have to rise about 205-fold to reach it.
Thinly traded: LIMNW traded about $3 a day over the last 30 days, and on only 4 of 22 trading days. With so little trading you may not be able to buy or sell near the price shown; use a limit order.
Key terms
- Strike per share
- $575.00
- Shares per warrant
- 1/50
- Cash to exercise one warrant
- $11.50
- Expiry
- 2030-04-30
- Redemption trigger
- $900.00
- Cashless exercise
- allowed
- Break-even stock price
- $577.11
Checked against the issuer's SEC filing of 2026. The terms were first set out in its S-1/A of 2025-07-28.
Redemption risk Low
LIMN closed at or above $900.00 on 0 of the last 30 trading days. The company can call the warrants once it reaches 20, so 20 more days above the trigger would be enough.
- Trigger price
- $900.00
- Last close
- $2.81 (0% of trigger)
- Days at or above, last 30
- 0 (needs 20)
The usual rule: 20 closes at or above the trigger within 30 trading days, then 30 days' notice. Some companies use a different test; check the warrant agreement. Counted from daily closes up to 2026-11-20. Follow LIMNW to get an email when it gets close.
Exercise calculator
Each warrant buys 1/50 share at $575.00. Before expiry a warrant usually sells for more than its exercise value, because it still has time left. Fees and taxes are not included. Arithmetic, not investment advice.
Company and stock
- Company
- Liminatus Pharma, Inc.
- Underlying stock
- LIMN
- Share price
- $2.81
- Market cap
- $3.77M
- Shares outstanding
- 1.34M
- 12-month range
- $2.52 – $102.50
- 12-month change
- -95%
- Value of all listed warrants
- $214.99K (5.7% of market cap)
- Industry
- Biological Products, (No Diagnostic Substances)
- Head office
- Cerritos, CA
- Incorporated in
- Delaware
Market cap is the last share price times shares outstanding (as of 2026-08-20). Industry and head office are as the company reports them to the SEC. All SEC filings for this company.
Model value Pro · free for now
The stock is at 0% of the strike; this far from it the answer is mostly a guess about volatility.
- Last price
- $0.0422
- Low and high estimate
- $0.0000 – $0.0007
- Stock volatility, measured
- 175%
- Volatility we use
- 50% · 80% · 100%
- Volatility the price implies
- 231%
- Redemption trigger
- $900.00
- Effect of dilution
- −6.8%
- Method
- day-by-day tree with the redemption trigger
The estimate uses a volatility below the one measured, because measured volatility overstates what the market pays for. Not investment advice.
Dilution
- Shares outstanding
- 1.34M
- Listed warrants
- 5.09M
- Dilution if all exercised
- 7.6%
Warrant count from the data the company files with the SEC.
Filings
- 8-KCurrent report: other events
- NT 10-QQuarterly report will be late
- 8-KCurrent report: material agreement; unregistered sale of shares
- 8-KCurrent report: delisting notice; investor update Key
- 8-KCurrent report: delisting notice; holders' rights changed; charter or bylaws changed; investor update Key
- 10-QQuarterly report
- 8-KCurrent report: shareholder vote results
- 8-KCurrent report: other events
- 8-KCurrent report: delisting notice; other events Key
- SCHEDULE 13D/ALarge holder's stake (5% or more) (amended)
The company's latest SEC filings, checked every night. Insider trades and routine SEC paperwork are left out. All SEC filings for this company.
Events
- Terms checked against an SEC filing
- Merger closed; the warrants became warrants of the combined company
Questions about LIMNW
When does the LIMNW warrant expire?
LIMNW expires on April 30, 2030.
What is the strike price of LIMNW?
$575.00 per share; each warrant converts into 1/50 share, so exercising one warrant costs $11.50.
Can Liminatus Pharma, Inc. redeem the LIMNW warrants early?
Yes. The company can call them if the share price reaches $900.00 for the required period (usually 20 of 30 trading days).
How many LIMNW warrants are outstanding?
5.09M listed warrants, equal to 7.6% dilution if all are exercised.
Related warrants
Get an email when alerts open
Follow LIMNW with the button at the top to get its alerts. Alerts are coming soon; leave your email and we will tell you when they open.

